TR200000224T2 - Nükleotid analog kompozisyonlar. - Google Patents
Nükleotid analog kompozisyonlar.Info
- Publication number
- TR200000224T2 TR200000224T2 TR2000/00224T TR200000224T TR200000224T2 TR 200000224 T2 TR200000224 T2 TR 200000224T2 TR 2000/00224 T TR2000/00224 T TR 2000/00224T TR 200000224 T TR200000224 T TR 200000224T TR 200000224 T2 TR200000224 T2 TR 200000224T2
- Authority
- TR
- Turkey
- Prior art keywords
- nucleotide analog
- analog compositions
- compositions
- adefovir dipivoxil
- crystallized
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Abstract
Bulus, adefovir dipivoksilin kristalize biçimlerini ve kristalleri hazirlamak için yöntemler saglar. Bu bulusun kompozisyon ve yöntemleri, kristalize adefovir dipivoksilin genis ölçekli sentezleri, ya da bunlarin tedavi amaçli dozajlara formülasyonu için, arzulanan özelliklere sahiptir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5377197P | 1997-07-25 | 1997-07-25 | |
US90074597A | 1997-07-25 | 1997-07-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200000224T2 true TR200000224T2 (tr) | 2000-07-21 |
Family
ID=26732226
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00117T TR200200117T2 (tr) | 1997-07-25 | 1998-07-23 | Nükleotid analog kompozisyonlar |
TR2002/00137T TR200200137T2 (tr) | 1997-07-25 | 1998-07-23 | Nükleotid analog kompozisyonlar. |
TR2000/00224T TR200000224T2 (tr) | 1997-07-25 | 1998-07-23 | Nükleotid analog kompozisyonlar. |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00117T TR200200117T2 (tr) | 1997-07-25 | 1998-07-23 | Nükleotid analog kompozisyonlar |
TR2002/00137T TR200200137T2 (tr) | 1997-07-25 | 1998-07-23 | Nükleotid analog kompozisyonlar. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0996430B1 (tr) |
JP (4) | JP3573713B2 (tr) |
KR (3) | KR100700087B1 (tr) |
CN (2) | CN1274700C (tr) |
AR (1) | AR016548A1 (tr) |
AT (3) | ATE228357T1 (tr) |
AU (1) | AU747163B2 (tr) |
BR (1) | BR9811552A (tr) |
CA (3) | CA2596320C (tr) |
CO (1) | CO4980869A1 (tr) |
DE (3) | DE69826735T2 (tr) |
DK (1) | DK0996430T3 (tr) |
ES (3) | ES2229029T3 (tr) |
HK (5) | HK1046357B (tr) |
ID (1) | ID28006A (tr) |
IL (1) | IL133461A (tr) |
IN (1) | IN190037B (tr) |
MY (1) | MY129451A (tr) |
NZ (1) | NZ501659A (tr) |
PT (3) | PT1256584E (tr) |
SI (2) | SI1256584T1 (tr) |
TR (3) | TR200200117T2 (tr) |
TW (1) | TW584635B (tr) |
WO (1) | WO1999004774A2 (tr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2596320C (en) * | 1997-07-25 | 2008-12-23 | Gilead Sciences, Inc. | Nucleotide analog compositions |
TWI230618B (en) * | 1998-12-15 | 2005-04-11 | Gilead Sciences Inc | Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same |
US6635278B1 (en) * | 1998-12-15 | 2003-10-21 | Gilead Sciences, Inc. | Pharmaceutical formulations |
HRP20160074B1 (hr) | 2000-07-21 | 2021-09-03 | Gilead Sciences, Inc. | Prolijekovi koji su fosfonatni analozi nukleotida i metode njihovog odabira te njihova priprava |
NZ536328A (en) | 2002-05-13 | 2007-11-30 | Metabasis Therapeutics Inc | Novel phosphonic acid based prodrugs of PMEA and its analogues |
EP1504014B1 (en) | 2002-05-13 | 2015-12-02 | Metabasis Therapeutics, Inc. | Process for preparation of cyclic prodrugs of pmea and pmpa |
US7417036B2 (en) | 2002-11-12 | 2008-08-26 | Tianjin Kinsly Pharmaceutical Co. Ltd. | Crystal form of adefovir dipivoxil and its preparation |
CN100383149C (zh) * | 2002-11-12 | 2008-04-23 | 天津帝士力投资控股集团有限公司 | 一种新的晶状埃地双酯及其组合物 |
CN1303089C (zh) * | 2002-11-19 | 2007-03-07 | 天津药物研究院 | 阿德福韦酯结晶形态及其制备方法 |
CN100415756C (zh) * | 2003-10-14 | 2008-09-03 | 沈阳药科大学 | 草酸阿地福韦酯及其晶型和制备方法及用途 |
CN100358907C (zh) * | 2004-03-31 | 2008-01-02 | 河北医科大学生物医学工程中心 | 一种非晶状阿德福韦酯的制备方法 |
CN100374118C (zh) * | 2004-05-20 | 2008-03-12 | 江苏吴中中药研发有限公司 | 含有阿德福韦酯的滴丸剂及其制备方法 |
RU2006138907A (ru) | 2004-06-08 | 2008-07-20 | Метабазис Терапеутикс | Синтез сложных циклических эфиров с применением кислоты льюиса |
CN102228463B (zh) * | 2005-06-13 | 2012-12-19 | 博瑞生物医药技术(苏州)有限公司 | 泰诺福韦的晶体 |
CN100395248C (zh) * | 2006-05-26 | 2008-06-18 | 华东理工大学 | 一种9-(二乙氧基磷酰基甲氧基乙基)-腺嘌啉的制备方法 |
ITMI20071594A1 (it) * | 2007-08-02 | 2009-02-03 | Solmag Spa | Forma cristallina monoidrata di adefovir dipivoxil |
CN101343290B (zh) * | 2008-05-24 | 2011-02-02 | 广东肇庆星湖生物科技股份有限公司 | 一种阿德福韦酯无水结晶物的制备方法、所得的阿德福韦酯无水结晶物及其应用 |
WO2010005195A2 (ko) * | 2008-07-07 | 2010-01-14 | (주)아모레퍼시픽 | 아데포버 디피복실의 결정형 l의 제조방법 |
KR20100031045A (ko) | 2008-09-11 | 2010-03-19 | 씨제이제일제당 (주) | 아데포비어 디피복실의 정제방법 |
US20110201575A1 (en) * | 2008-09-17 | 2011-08-18 | Cj Cheiljedang Corporation | Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof |
KR20100032803A (ko) * | 2008-09-18 | 2010-03-26 | 씨제이제일제당 (주) | 아데포비어디피복실의 개선된 제조방법 |
KR20100061401A (ko) * | 2008-11-28 | 2010-06-07 | (주)아모레퍼시픽 | 아데포버 디피복실의 결정형, 그 제조방법 및 그를 포함하는 약제학적 조성물 |
US9169257B2 (en) | 2009-03-26 | 2015-10-27 | Daewoong Pharmaceutical Co., Ltd. | Crystal forms of adefovir dipivoxil and processes for preparing the same |
KR20100113302A (ko) * | 2009-04-13 | 2010-10-21 | 한미홀딩스 주식회사 | 결정형 아데포비어 디피복실의 제조방법 및 이에 사용되는 아데포비어 디피복실 부탄올레이트 |
KR101528754B1 (ko) * | 2009-04-14 | 2015-06-17 | 중앙대학교 산학협력단 | 신규한 복합결정형의 화합물, 그 제조방법 및 이를 포함하는 약제학적 조성물 |
KR100971486B1 (ko) * | 2009-06-11 | 2010-07-21 | 주식회사 셀트리온화학연구소 | 아데포비어 다이피복실 말론산염 및 이를 포함하는 약제학적 조성물 |
KR101089620B1 (ko) * | 2009-07-20 | 2011-12-06 | 경희대학교 산학협력단 | 무수결정형 아데포비어 디피복실 및 이온성 액체를 사용한 이의 제조 방법 |
WO2011016611A2 (ko) * | 2009-08-03 | 2011-02-10 | 제일약품주식회사 | 새로운 결정형을 갖는 아데포비어 디피복실, 이의 제조방법 및 이를 유효성분으로 함유하는 만성 b형 간염의 예방 또는 치료용 조성물 |
KR101129575B1 (ko) * | 2009-09-02 | 2012-03-28 | 경희대학교 산학협력단 | 반수화물 아데포비어 디피복실 및 이온성 액체를 사용한 이의 제조 방법 |
KR101048024B1 (ko) * | 2009-10-09 | 2011-07-13 | 주식회사 삼오제약 | 9-(2-포스포닐메톡시에틸)아데닌, 아데포비아 디피복실 및 무정형 아데포비아 디피복실의 제조방법 |
EP2343056A1 (en) | 2009-12-30 | 2011-07-13 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Producing stable adefovir dipivoxil solid dispersions |
WO2012032541A1 (en) * | 2010-09-06 | 2012-03-15 | Matrix Laboratories Ltd | "adefovir dipivoxil pseudopolymorph" |
WO2012062835A1 (en) | 2010-11-12 | 2012-05-18 | Glaxo Wellcome Manufacturing Pte Ltd | Novel pharmaceutical compositions |
CN102250146A (zh) * | 2011-05-27 | 2011-11-23 | 扬州三友合成化工有限公司 | 抗乙肝药物阿德福韦的一种合成方法 |
KR101357687B1 (ko) * | 2011-11-25 | 2014-02-05 | 숭실대학교산학협력단 | 고분자 첨가제를 이용한 아데포비어 디피복실 복합체의 결정입자 제어방법 및 이의 응용 |
KR101258678B1 (ko) | 2012-02-29 | 2013-04-26 | 제일약품주식회사 | 새로운 결정형을 갖는 아데포비어 디피복실, 이의 제조방법 및 이를 유효성분으로 함유하는 만성 β형 간염의 예방 또는 치료용 조성물 |
CN107312039B (zh) | 2012-08-30 | 2019-06-25 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药的制备方法 |
CN102816184B (zh) * | 2012-09-07 | 2015-11-18 | 山东大学 | (2-(2-氧基-4-硫代嘧啶)乙氧基)甲基膦酸酯类衍生物及其制备与应用 |
CN103709198A (zh) * | 2012-09-28 | 2014-04-09 | 江苏天士力帝益药业有限公司 | 一种阿德福韦酯的结晶方法 |
CN103333208B (zh) * | 2013-06-04 | 2016-05-11 | 广州晶莱医药科技有限公司 | 阿德福韦酯马来酸盐及其制备方法和组合物 |
JP2017512183A (ja) | 2014-02-13 | 2017-05-18 | リガンド・ファーマシューティカルズ・インコーポレイテッド | プロドラッグ化合物およびそれらの使用 |
CN106687118A (zh) | 2014-07-02 | 2017-05-17 | 配体药物公司 | 前药化合物及其用途 |
EP3372227A1 (en) | 2017-03-06 | 2018-09-12 | MH10 Spolka z ograniczona odpowiedzialnoscia | Tablet formulation of adefovir dipivoxil |
US11970482B2 (en) | 2018-01-09 | 2024-04-30 | Ligand Pharmaceuticals Inc. | Acetal compounds and therapeutic uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE167679T1 (de) * | 1990-09-14 | 1998-07-15 | Acad Of Science Czech Republic | Wirkstoffvorläufer von phosphonaten |
CA2126601A1 (en) * | 1993-06-29 | 1994-12-30 | Mitsubishi Chemical Corporation | Phosphonate-nucleotide ester derivatives |
JP4033494B2 (ja) * | 1996-07-26 | 2008-01-16 | ギリヤド サイエンシーズ, インコーポレイテッド | ヌクレオチドアナログ |
CA2596320C (en) * | 1997-07-25 | 2008-12-23 | Gilead Sciences, Inc. | Nucleotide analog compositions |
-
1998
- 1998-07-23 CA CA002596320A patent/CA2596320C/en not_active Expired - Lifetime
- 1998-07-23 WO PCT/US1998/015304 patent/WO1999004774A2/en active IP Right Grant
- 1998-07-23 DK DK98937988T patent/DK0996430T3/da active
- 1998-07-23 NZ NZ501659A patent/NZ501659A/xx not_active IP Right Cessation
- 1998-07-23 JP JP2000503833A patent/JP3573713B2/ja not_active Expired - Lifetime
- 1998-07-23 TR TR2002/00117T patent/TR200200117T2/tr unknown
- 1998-07-23 DE DE69826735T patent/DE69826735T2/de not_active Expired - Lifetime
- 1998-07-23 EP EP98937988A patent/EP0996430B1/en not_active Expired - Lifetime
- 1998-07-23 ES ES02016428T patent/ES2229029T3/es not_active Expired - Lifetime
- 1998-07-23 BR BR9811552-9A patent/BR9811552A/pt not_active Application Discontinuation
- 1998-07-23 KR KR1020057020624A patent/KR100700087B1/ko not_active IP Right Cessation
- 1998-07-23 AT AT98937988T patent/ATE228357T1/de active
- 1998-07-23 CA CA002298057A patent/CA2298057C/en not_active Expired - Lifetime
- 1998-07-23 ID IDW20000153A patent/ID28006A/id unknown
- 1998-07-23 AT AT02016429T patent/ATE277937T1/de active
- 1998-07-23 DE DE69809749T patent/DE69809749T2/de not_active Expired - Lifetime
- 1998-07-23 IL IL13346198A patent/IL133461A/xx not_active IP Right Cessation
- 1998-07-23 CN CNB001370596A patent/CN1274700C/zh not_active Expired - Lifetime
- 1998-07-23 CN CN988037440A patent/CN1216062C/zh not_active Expired - Lifetime
- 1998-07-23 TR TR2002/00137T patent/TR200200137T2/tr unknown
- 1998-07-23 KR KR1019997012410A patent/KR100618663B1/ko not_active IP Right Cessation
- 1998-07-23 AU AU86609/98A patent/AU747163B2/en not_active Expired
- 1998-07-23 SI SI9830712T patent/SI1256584T1/xx unknown
- 1998-07-23 SI SI9830716T patent/SI1256585T1/xx unknown
- 1998-07-23 AT AT02016428T patent/ATE277936T1/de active
- 1998-07-23 KR KR1020057020625A patent/KR100700089B1/ko not_active IP Right Cessation
- 1998-07-23 TR TR2000/00224T patent/TR200000224T2/tr unknown
- 1998-07-23 PT PT02016428T patent/PT1256584E/pt unknown
- 1998-07-23 ES ES02016429T patent/ES2229030T3/es not_active Expired - Lifetime
- 1998-07-23 CA CA002596497A patent/CA2596497C/en not_active Expired - Lifetime
- 1998-07-23 PT PT98937988T patent/PT996430E/pt unknown
- 1998-07-23 ES ES98937988T patent/ES2187991T3/es not_active Expired - Lifetime
- 1998-07-23 DE DE69826734T patent/DE69826734T2/de not_active Expired - Lifetime
- 1998-07-23 PT PT02016429T patent/PT1256585E/pt unknown
- 1998-07-24 IN IN2176DE1998 patent/IN190037B/en unknown
- 1998-07-24 TW TW087112169A patent/TW584635B/zh not_active IP Right Cessation
- 1998-07-24 CO CO98042226A patent/CO4980869A1/es unknown
- 1998-07-24 MY MYPI98003396A patent/MY129451A/en unknown
- 1998-07-27 AR ARP980103692A patent/AR016548A1/es active IP Right Grant
-
2002
- 2002-09-06 HK HK02106589.2A patent/HK1046357B/zh not_active IP Right Cessation
-
2003
- 2003-04-02 HK HK03102359A patent/HK1051693A1/xx not_active IP Right Cessation
- 2003-04-02 HK HK03102360A patent/HK1051694A1/xx not_active IP Right Cessation
- 2003-05-26 JP JP2003148228A patent/JP4452034B2/ja not_active Expired - Lifetime
-
2005
- 2005-05-18 JP JP2005145754A patent/JP2005306879A/ja not_active Withdrawn
-
2006
- 2006-10-26 HK HK06111840.3A patent/HK1091212A1/xx not_active IP Right Cessation
- 2006-10-26 HK HK06111839.6A patent/HK1091211A1/xx not_active IP Right Cessation
-
2009
- 2009-07-01 JP JP2009157357A patent/JP2009263389A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200000224T2 (tr) | Nükleotid analog kompozisyonlar. | |
CO5180642A1 (es) | Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion | |
SE9702001D0 (sv) | Novel compounds | |
ATE267200T1 (de) | Bicyclische kinase inhibitoren | |
EE200000318A (et) | Uudsed ühendid | |
PL366198A1 (en) | Novel compounds | |
CA2359510A1 (en) | .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | |
AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
SE9901875D0 (sv) | Novel compounds | |
SE9704546D0 (sv) | Novel compounds | |
NO965516L (no) | Sterolderivater anvendt til regulering av meiose | |
SE9902765D0 (sv) | Novel compounds | |
ATE240303T1 (de) | 1,2,4-triazol-3-thion verbindungen | |
GB0120461D0 (en) | Novel compounds | |
SE9902551D0 (sv) | Novel compounds | |
MY134019A (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
TR200001329T2 (tr) | Pirrolo (3,2-b) piridin için yöntemler ve ara bileşikler | |
ES2182785T3 (es) | Nuevos derivados de esteroides 11,beta-sustituidos, sus procedimientos de preparacion y los intermedios de este procedimiento, su aplicacion como medicamentos y composiciones que los contienen. |